Other immunology — Revenue

Products & Services · Revenue

Eli Lilly Other immunology — Revenue increased by 6.1% to $489.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 532.6%, from $77.30M to $489.00M. Over 4 years (FY 2021 to FY 2025), Other immunology — Revenue shows an upward trend with a 167.5% CAGR.

Analysis

StatementSegment
First reportedQ1 2016
Last reportedQ4 2025
Rolls up toTotal Revenue
Metric ID: lly_segment_other_immunology_revenues

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$7.90M$4.90M$3.20M$4.50M$4.00M$3.60M$20.00M$22.00M$5.70M$11.40M$76.10M$12.50M$30.00M$55.30M$77.30M$326.10M$408.00M$460.90M$489.00M
QoQ Change—-38.0%-34.7%+40.6%-11.1%-10.0%+455.6%+10.0%-74.1%+100.0%+567.5%-83.6%+140.0%+84.3%+39.8%+321.9%+25.1%+13.0%+6.1%
YoY Change————-49.4%-26.5%+525.0%+388.9%+42.5%+216.7%+280.5%-43.2%+426.3%+385.1%+1.6%>999%>999%+733.5%+532.6%
Range$3.20M – $489.00M
CAGR+150.1%
Avg YoY Growth+478.8%
Median YoY Growth+385.1%
Current Streak7 quarters growth

Frequently Asked Questions

What is Eli Lilly's other immunology — revenue?
Eli Lilly (LLY) reported other immunology — revenue of $489.00M in Q4 2025.
How has Eli Lilly's other immunology — revenue changed year-over-year?
Eli Lilly's other immunology — revenue increased by 532.6% year-over-year, from $77.30M to $489.00M.
What is the long-term trend for Eli Lilly's other immunology — revenue?
Over 4 years (2021 to 2025), Eli Lilly's other immunology — revenue has grown at a 167.5% compound annual growth rate (CAGR), from $32.90M to $1.68B.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.